The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

NARecruitingINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

March 30, 2028

Study Completion Date

January 31, 2032

Conditions
Aortoiliac Occlusive DiseasePeripheral Arterial Disease
Interventions
DEVICE

Stenting of the Common and/or External Iliac Arteries with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

Treatment of target lesions in the common and/or external iliac arteries by stenting with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis.

DEVICE

Stenting of the Common and/or External Iliac Arteries with Bare Metal Stent

Treatment of target lesions in the common and/or external iliac arteries by stenting with a commercially available bare metal stent that is approved for treatment of the disease.

Trial Locations (7)

19104

RECRUITING

University of Pennsylvania, Philadelphia

33801

RECRUITING

Radiology and Imaging Specialists of Lakeland, Lakeland

75390

NOT_YET_RECRUITING

The University of Texas Southwestern Medical Center, Dallas

80229

RECRUITING

North Suburban Medical Center, Denver

Unknown

RECRUITING

Krankenhaus der Barmherzigen Brüder, Regensburg

RECRUITING

Rijnstate Hospital, Arnhem

RECRUITING

Auckland City Hospital, Auckland

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY